FDA
-
-
-
-
-
-
-
PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Diseas
-
-
-
-
-
-
-
Pharmadrug Advances PD-001, Its Patented, Improved Version of Cepharanthine for Oncology and Infectious Disease
-
-
-
-
-
-
-
PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases
-
327,672 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

